Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 4 53-4, 2003, Pages

  Kook, Hyun ^a   Itoh, Hiroshi ^b   Choi, Bong Seok ^a   Sawada, Naoki ^b   Doi, Kentaro ^b   Hwang, Tae Ju ^a   Kim, Kyung Keun ^a   Arai, Hiroshi ^b   Baik, Yung Hong ^a   Nakao, Kazuwa ^b  

^a Chonnam National University Medical School   (South Korea)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Akt protein kinase B; cGMP dependent protein kinase; Extracellular signal regulated kinase 1 2

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ATRIAL NATRIURETIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE; WORTMANNIN;

ARTERY ENDOTHELIUM; ARTICLE; CELL COUNT; CELL MIGRATION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN;

EID: 0037378364     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00414.2002     Document Type: Article

References (46)

1. Arnold F and West DC. Angiogenesis in wound healing. Pharmacol Ther 52: 407-422, 1991.
2. Ashur-Fabian O, Perl O, Lilling G, Fridkin M, and Gozes I. SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survival. Peptides 20: 629-633, 1999.
3. Chrisman TD and Garbers DL. Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts. J Biol Chem 274: 4293-4299, 1999.
4. De Feo ML, Franceschelli F, Frediani U, Tosti-Guerra C, Crescioli C, Tanini A, Bartolini O, Becorpi A, Serio M, and Brandi ML. Natriuretic hormone receptors and actions on bone endothelial cells. Endocrinology 133: 1759-1766, 1993.
5. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
6. Doi K, Ikeda T, Itoh H, Ueyama K, Hosoda K, Ogawa Y, Yamashita J, Chun TH, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Saito T, Sone M, Yamahara K, Kook H, Komeda M, Ueda M, and Nakao K. C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler Thromb Vasc Biol 21: 930-936, 2001.
7. 1 growth inhibition of cultured vascular smooth muscle cells. Biochem Biophys Res Commun 239: 889-894, 1997.
8. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, and Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665, 1997.
9. Ettenson DS and Gotlieb AI. Centrosomes, microtubules, and microfilaments in the reendothelialization and remodeling of double-sided in vitro wounds. Lab Invest 66: 722-733, 1992.
10. Folkman J. Angiogenesis: initiation and control. Ann NY Acad Sci 401: 212-227, 1982.
11. Franke TF, Kaplan DR, and Cantley LC. PI3K: downstream AKT blocks apoptosis. Cell 88: 435-437, 1997.
12. Fujio Y and Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchoragedependent manner. J Biol Chem 274: 16349-16354, 1999.
13. Fulton D, Gratton JP, McCabe T, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
14. Gruber BL, Marchese MJ, and Kew R. Angiogenic factors stimulate mast-cell migration. Blood 86: 2488-2493, 1995.
15. Hood J and Granger HJ. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 273: 23504-23508, 1998.
16. Ikeda M, Kohno M, and Takeda T. Inhibition by cardiac natriuretic peptides of rat vascular endothelial cell migration. Hypertension 26: 401-405, 1995.
17. Itoh H, Pratt RE, and Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 86: 1690-1697, 1990.
18. Itoh H, Pratt RE, Ohno M, and Dzau VJ. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 19: 758-761, 1992.
19. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, and Evan G. Suppression of c-Myc-induced apoptosis by Ras signaling through PI (3)K and PKB. Nature 385: 544-548, 1997.
20. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Ueda M, and Yoshikawa J. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ Res 81: 585-590, 1997.
21. Komatsu Y, Itoh H, Suga S, Ogawa Y, Hama N, Kishimoto I, Nakagawa O, Igaki T, Doi K, Yoshimasa T, and Nakao K. Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition. Circ Res 78: 606-614, 1996.
22. Komatsu Y, Nakao K, Itoh H, Suga S, Ogawa Y, and Imura H. Vascular natriuretic peptide. Lancet 340: 622, 1992.
23. Kook H, Rhee JH, Lee SE, Kang SY, Chung SS, Cho KW, and Baik YH. Activation of particulate guanylyl cyclase by Vibrio vulnificus hemolysin. Eur J Pharmacol 365: 267-272, 1999.
24. Li J, Yang S, and Billiar TR. Cyclic nucleotides suppress tumor necrosis factor α-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation. J Biol Chem 275: 13026-13034, 2000.
25. Matsumoto T, Yokote K, Tamura K, Takemoto M, Ueno H, Saito Y, and Mori S. Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. J Biol Chem 274: 13954-13960, 1999.
26. Morales-Ruiz M, Fulton D, Sowa G, Languino LR, Fujio Y, Walsh K, and Sessa WC. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 86: 892-896, 2000.
27. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda G, and Ziche M. Nitric oxide mediates mitogenic effects of VEGF on coronary venular endothelium. Am J Physiol Heart Circ Physiol 270: H411-H415, 1996.
28. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, and Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87: 1402-1412, 1991.
29. Ojaniemi M and Vuori K. Epidermal growth factor modulate tyrosine phosphorylation of p130Cas. Involvement of phosphatidylinositol 3-kinase and actin cytoskeleton. J Biol Chem 272: 25993-25998, 1997.
30. Okumura M, Okuda T, Nakamura T, and Yajima M. Acceleration of wound healing in diabetic mice by basic fobroblast growth factor. Biol Pharm Bull 19: 530-535, 1996.
31. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, and Ziche M. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 273: 4220-4226, 1998.
32. Postel-Vinay MV, de Mello Coelho V, Gagnerault MC, and Dardenne M. Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology 138: 1816-1820, 1997.
33. Robinson MJ and Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180-186, 1997.
34. Rousseau S, Houle F, Kotanides H, Witte L, Waltenberger J, Landry J, and Huot J. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem 275: 10661-10672, 2000.
35. Rousseau S, Houle F, Landry J, and Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15: 2169-2177, 1997.
36. Shin BA, Ahn KY, Kook H, Koh JT, Kang IC, Lee HC, and Kim KK. Overexpressed human RAD50 exhibits cell death in a p21(WAF1/CIP1)-dependent manner: its potential utility in local gene therapy of tumor. Cell Growth Differ 12: 243-254, 2001.
37. Stoker M and Gherardi E. Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta 1072: 81-102, 1991.
38. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, and Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system." J Clin Invest 90: 1145-1149, 1992.
39. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, and Nakagawa O. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res 71: 34-39, 1992.
40. Sugawara A, Nakao K, Morii N, Yamada T, Itoh H, Shiono S, Saito Y, Mukoyama M, Arai H, Nishimura K, Obata K, Yasue H, Ban T, and Imura H. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. J Clin Invest 81: 1962-1970, 1988.
41. Takaishi K, Sasaki T, Kato M, Yamochi W, Kuroda S, Nakamura T, Takeichi M, and Takai Y. Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene 9: 273-279, 1994.
42. Villablanca AC, Murphy CJ, and Reid TW. Growth-promoting effects of substance P on endothelial cells in vitro. Synergism with calcitonin gene-related peptide, insulin, and plasma factors. Circ Res 75: 1113-1120, 1994.
43. Von der Leyen, Gibbons G.F, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, and Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92: 1137-1141, 1995.
44. Whitmarsh AJ and Davis RJ. Thranscription factor AP-1 regulation by migoten-activated protein kinase signal gransduction pathways. J Mol Med 74: 589-607, 1996.
45. Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, and Yu D. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Cancer Res 61: 1727-1732, 2001.
46. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, and Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994.